Objective: To describe symptoms, physical examination findings, and set-point viral load associated with acute HIV seroconversion in a heterosexual cohort of HIVdiscordant couples in Zambia.
Introduction
Identifying acute HIV infection is of interest clinically, for studies or pathogenesis, for HIV prevention and vaccine development, and for surveillance [1] . Manifestations of chronic HIV infection differ substantially in Africa compared with developed countries [2, 3] , and differ between East-Central and Southern African cohorts [4] [5] [6] . Similarly, there are several factors impacting early infection that differ based on population genetics and the subtype of virus that predominates within a particular region. Studies in newly infected Zambian individuals have identified a unique set of favorable HLA class I alleles that modulate both peak and early set-point viral load [7, 8] , and mutations selected in a chronically infected partner that allow escape from immune pressure directed by these alleles have also been shown to reduce early setpoint viral load in the partner to whom they transmit [9] . In the Zambian cohort under study here, genotypic analyses of the viruses that initiate infection and the viral quasispecies in transmitting partners have shown that in approximately 90% of transmissions a single genetic variant establishes infection [10, 11] . Despite this, in a recent study of primary HIV-1 subtype C infection, a high proportion of individuals who maintained high plasma HIV-1 RNA load after acute infection were identified [12] . Thus, understanding the early events of infection, including initial viral pathogenesis and early host immune responses may enable new vaccine strategies.
To date, most descriptions of the clinical features of seroconverting persons have been reported from countries with predominately subtype B HIV epidemics [13, 14] , and the majority of previous studies of acute infection recruited symptomatic study populations, with few notable exceptions [15] , and thus give a biased view of acute infection. We used data from a large cohort of HIV-discordant couples in Lusaka, Zambia, where HIVsubtype C predominates, to characterize self-reported and treated symptoms and physical examination findings associated with HIV seroconversion. We further analyzed the relationship between the number of symptoms and physical examination findings at HIV seroconversion and set-point HIV viral load.
Methods

Patient population
The Zambia-Emory HIV Research Project provides HIV counseling and testing to couples in Zambia; from 1995 to 2009, couples in whom one partner was HIVpositive and one partner was HIV-negative (i.e., HIV serodiscordant couples) were enrolled in an ongoing prospective cohort of discordant couples [16] [17] [18] . As part of the follow-up activities in the research studies, HIV-negative partners attended a study visit every 3 months [19] . At each visit, chart review and interview were used to inventory self-reported or treated symptoms that occurred since the last 3-month visit. HIV testing was conducted at each 3-month visit using screening and confirmatory rapid tests, followed by another rapid test for those with discrepant or indeterminate confirmatory results [20] . Once yearly, and at any visit in which a new infection was detected, a complete physical examination was performed. Viral load testing began in 1998 when facilities for plasma banking were installed.
Measures
For the purpose of this analysis, we considered five selfreported or treated symptoms (malaria syndrome, chronic diarrhea, asthenia, night sweats, and oral candidiasis) and seven physical examination findings (neck, axillary, or inguinal adenopathy, each unilateral or bilateral; and dermatosis) as possible predictors of HIV seroconversion. The selection of these factors was based on previously reported descriptions of the HIV seroconversion syndrome in countries with predominantly subtype B epidemics [21] [22] [23] [24] [25] [26] [27] .
HIV viral load was determined with the Amplicor HIV-1 Monitor test, v1.5 (Roche Molecular Diagnostics, Pleasanton, California, USA). HIV subtype was determined as previously described [28] . Briefly, sequences of eight partially overlapping regions in gag, three in gp120, one in gp41, and one in the long term repeat were subjected to preliminary phylogenetic tree analyses to identify all circulating HIV-1 group M subtypes. Full-length and nonrecombinant reference sequences representing these subtypes were then obtained from the Los Alamos HIV Sequence Database and subjected to pair-wise sequence comparisons in the genomic regions corresponding to the PCR amplification products.
Analysis
We conducted four primary analyses: an analysis of self-reported or treated symptoms associated with HIV seroconversion (defined as being the first 3-month interval in which one or more positive HIV rapid test results were reported) relative to HIV-negative and HIVpositive intervals; an analysis of physician-documented physical examination findings and erythrocyte sedimentation rate (ESR) associated with HIV seroconversion relative to HIV-negative and HIV-positive intervals; an evaluation of a clinical scoring system predictive of seroconversion; and an analysis of the relationship between number of symptoms and physical examination findings at HIV seroconversion, and set-point HIV RNA concentration (i.e., HIV viral load). For the analysis of symptoms associated with HIV seroconversion (considering both HIV-negative and HIV-positive intervals as referent groups, separately), we conducted logistic regression analyses with an outcome of HIV seroconversion, and the five self-reported symptoms as independent variables. Models controlled for age, sex, and repeated observations. PROC GENMOD (SAS Institute, Cary, North Carolina, USA) was used to control for repeated observations of individuals, and robust variance estimates were used to calculate 95% confidence intervals for the adjusted odds ratios. Because we considered all of the independent variables to be plausibly associated with our outcome of seroconversion, we did not reduce the model by removing nonsignificant factors. We checked for all two-way associations using a forward selection procedure with an entry criterion of a ¼ 0.002 (reflecting a Bonferroni-type correction for testing of 28 possible two-way interactions). For the analysis of physiciandocumented physical examination findings associated with HIV seroconversion, a similar analytic approach was used, but the total number of intervals of observation was lower because physical examinations occurred only annually and at the time of HIV seroconversion.
Index of significantly associated symptoms and physical examination findings
Symptoms and physical examination findings found to be significant in the multivariate models of seroconverting vs. HIV-negative intervals were used to construct an additive score. This analysis was limited to data from visits with both symptom inventories and physical examinations. Each symptom or physical examination finding contributed 1 point to the score. For each cutoff level of number of symptoms, sensitivity, specificity, positive predictive value (PPV), and negative predictive value were calculated.
For the analysis of the relationship between number of symptoms and physical examination findings and setpoint HIV viral load, we performed new HIV viral load tests on stored specimens. We considered a viral load to represent the set-point viral load if it met three criteria: taken more than 30 days after the first positive HIV antibody test; taken less than 3 years after the first positive HIV antibody test; and taken before the initiation of antiretroviral medications. For cases in which multiple candidate set-point viral load values were available, we used the earliest value that met all criteria. PROC GLM (SAS Institute) was used to conduct an analysis of variance, with the outcome being the log 10 of the viral load, and the independent variable being the number of self-reported symptoms, controlling for sex and year of first-positive HIV test. The results are reported as a P-value from the type III analysis. Type III partial sum of squares were chosen because our data were balanced, and all variables were included in the linear model.
Results
Cohort A total of 2388 HIV-negative partners were followed for a median of 18 months (IQR, 6-42 months for those who never seroconverted, and 6-36 months for seroconverters). A total of 429 seroconversions occurred, and of those, 387 were diagnosed based on an HIVantibody test, 41 were diagnosed based on a positive p24 test prior to development of a positive antibody test, and one was diagnosed by a positive HIV RNA test prior to development of a positive antibody test. Four hundred and seventeen (97%) had a 3 monthly visit with complete symptom data, and 361 (84%) had a physical examination at the time of detection of the new infection. Two hundred and ninety-one seroconverters (68%) had a follow-up viral load, which met criteria for a set-point viral load, and associated symptom and physical examination data. Nonseroconverters contributed 15 754 three-monthly visits with complete symptom data and 7833 interval visits with complete physical examination data. Seroconverters contributed 2920 HIVnegative interval visits with complete symptom data, and 1971 HIV-negative interval visits with complete physical examination data. HIV-positive patients contributed 12 857 HIV-positive interval visits with complete symptom data, and 7724 HIV-positive interval visits with complete physical examination data. Seroconverters contributed 5332 HIV-positive postseroconversion interval visits with complete symptom data, and 1550 HIV-positive interval visits with complete physical examination data.
The median age of seroconverters was 28, which was significantly different from the median age of HIVnegative (31) and HIV-positive intervals (30) . Women were significantly younger than men for all intervals. Median ESR for seroconverting intervals was 29, which was significantly different from the median ESR of HIVnegative (13) and HIV-positive intervals (33) . Women had consistently and significantly higher ESR for all intervals compared with men.
Of the 429 seroconverters included in the analysis, subtype data were available for 402 (93.7% of all seroconverters). Among those with available data, 391 (97.3%) were subtype C, four (1.0%) were subtype A, two (0.5%) were subtype G, two (0.5%) were subtype J, one (0.2%) was subtype C/G, one (0.2%) was subtype D, and one (0.2%) was recombinant.
Prevalence of symptoms and physical examination findings
Symptoms documented by self-report or treatment were uncommon at most follow-up seroconversion visits or nonseroconversion visits (Table 1 ). Most symptoms were not severe enough to prompt a clinical visit for treatment. Some symptoms (night sweats, chronic diarrhea, oral candidiasis) were early manifestations of HIV, with frequency and proportion treated similar among HIVpositive intervals compared with seroconvertors, and greater among seroconvertors compared with HIVnegative intervals. Malaria syndrome and asthenia were more common among seroconvertors compared with both HIV-negative and HIV-positive intervals. More than half of malaria syndrome events required treatment among seroconvertors. In contrast, more than half of malaria syndrome events among HIV-negative and HIVpositive intervals did not require treatment. All symptoms were more common among HIV-positive men than among HIV-positive women. A higher prevalence of symptoms among men was noted for night sweats and malaria in all serostatus groups, whereas oral candida was more common among HIV-negative women than among HIV-negative men.
Similarly, significant physical examination findings were not noted for most visits, whether seroconverting or nonseroconverting visits. Prevalence of adenopathy was lowest among HIV-negative intervals, intermediate among seroconverting intervals, and highest in HIV-positive intervals ( Table 1 ). Most adenopathies were significantly more common in men vs. women regardless of serostatus interval.
Symptoms and physical examination findings associated with seroconversion
Relative to HIV-negative intervals in multivariate models, seroconversion was associated with malaria syndrome among nondiarrheic patients, night sweats, and bilateral axillary, inguinal, and neck adenopathy. Relative to HIV-positive intervals in multivariate models, seroconversion was associated with asthenia, and malaria syndrome. Seroconverters were less likely than chronically HIV-infected men and women to have unilateral axillary and inguinal adenopathy, bilateral axillary and inguinal adenopathy, and dermatosis ( Table 2) .
Evaluation of index of symptoms and physical examination findings as a predictor of seroconversion
The additive score comprised significant symptoms and physical examination findings from the multivariate analysis of seroconversion vs. HIV-negative intervals: chronic diarrhea; night sweats; malaria syndrome; and any bilateral adenopathy. Of 7701 total intervals included, 4510 (58.6%) reported no symptoms, 3191 (41.4%) reported one or more symptoms, 706 (9.2%) reported two or more symptoms, 79 (1.0%) reported three or more symptoms, and six (0.1%) reported all four symptoms. Of the total intervals, 350 were seroconverting intervals and 7351 were nonseroconversion intervals. Sensitivity, specificity, PPV, and negative predictive value were calculated for the score at each possible cutoff of number of symptoms. Within 226 seroconverting intervals, one or more symptoms were reported. Sensitivity for this cutoff level was 64.6%, specificity was 59.7%, the positive predictive value was 7.1%, and the negative predictive value was 97.3%. Sensitivity, specificity, PPV, and NPV were also determined at each cutoff of number of symptoms and by sex. Men had a higher sensitivity at all cutoffs relative to women (73.0 vs. 57.6% for one or more symptoms, respectively), and PPV varied by sex and cutoff ( Table 3) .
Proportions of seroconverting and HIV-negative intervals were calculated by numbers of symptoms and physical examination findings were calculated. Although most (60%) HIV-negative intervals exhibited no associated symptoms, 65% of seroconverting intervals exhibited at least one symptom, with more men reporting one or more symptom compared with women (73 vs. 58%, respectively) ( Fig. 1) .
Association of symptoms of seroconversion and set-point viral load
The mean number of significant symptoms and physical examination findings (malaria syndrome, chronic diarrhea, night sweats, and any bilateral adenopathy) exhibited was 0.8 (range, 0-4). Increasing number of these symptoms and physical examination findings was positively associated with a higher set-point viral load for all seroconverters and for both men and women (Fig. 2 ).
Discussion
HIV seroconversion illness has been frequently described in countries with predominantly subtype B epidemics, but much less is reported about the clinical circumstances surrounding seroconversion in subtype C epidemics. Our report adds to the existing literature on this topic by examining data from a prospective cohort of HIVdiscordant couples undergoing regular HIV screening, allowing comparison of symptoms and signs in HIVnegative, seroconverting, and HIV-positive intervals in both men and women. We have also further previous reports by considering some clinical features in a graded way.
Although malaria-like illness and adenopathy were more common in HIV seroconverters than nonseroconverters in Zambia, most seroconverters in Zambia were not symptomatic. This corroborates findings in cohort studies from A and D clade areas in Uganda [13] and from US cohorts of gay men with B clade HIV [15] . Reports of seroconversions identified during screening of at-risk patients seeking clinical care in the West not surprisingly have much higher rates of symptoms, because these symptoms are likely what prompted them to seek treatment. In these series, fever, rash, athralgias, malaise, fatigue, and night sweats are reported by half to 89% of patients [24, 25] , often with a 'flu-like illness' [29] . In a study of acutely HIV-infected men seeking treatment for sexually transmitted diseases in Malawi, participants reported fever (56%), headache (44%), body ache (44%), or abdominal pain (44%), whereas chronically HIVinfected men more often reported genital ulcer disease (81%) and inguinal adenopathy (44%) [21] . In a Kenyan cohort study, 50 of 72 seroconvertors enrolled sought healthcare prior to diagnosis, of whom 29 were treated for malaria [30] . Manifestations of chronic HIV infection differ in East-Central vs. Southern Africa [4] , perhaps reflecting varying prevalences of pathogens such as tuberculosis. Our finding that most seroconversions in our Zambian cohort were asymptomatic may be because subtype C seroconversion are less likely to be symptomatic because our sampling was not related to careseeking behavior, or both.
Malaria syndrome was the most commonly exhibited symptom among all intervals in our cohort, with a significantly greater proportion of seroconverters exhibiting malaria syndrome vs. HIV-negative or positive intervals. Malaria syndrome may also be a culturally familiar -or culturally acceptable -marker for a collection of other symptoms suggestive of HIV infection, including fever, chills, and acute diarrhea [31] . A study of the relationship between falciparum malaria syndrome and HIV seropositivity in Zambia found that over 10% of patients presenting for suspect malaria syndrome were HIV seropositive without evidence of malaria syndrome infection [31] . The prevalence of malaria syndrome was significantly higher for men vs. women for all intervals, and notably so among seroconverting intervals, indicating that malaria syndrome may be more strongly associated with primary HIV infection in men vs. women. An early study of malaria and HIV in Kigali, Rwanda showed that HIV antibodies were more prevalent in women from the urban center than in those from the outskirts, whereas malaria parasites showed the opposite prevalence pattern; after stratifying by location, there was no association between HIV and the presence or degree of malaria parasitemia [32] . More recently, however, malaria parasitemia has been reported to be associated with prevalent HIV infection in Malawi [33] .
Chronic diarrhea, either treated or self-reported, was seen more frequently in seroconverting and HIV-positive intervals vs. HIV-negative intervals in bivariate analysis.
In an earlier analysis of 74 seroconverting men in this cohort, acute diarrhea was more likely to be treated (18%) or reported (31%) compared with HIV-negative men (8% treated, 21% reported) or HIV-positive men (14% treated, 26% reported) [34] .
Adenopathy has been commonly reported as a physical examination finding in patients with acute HIV infection [1, 23, 35, 36] . We found that bilateral, but not unilateral, adenopathy was significantly more common in HIV seroconverters than HIV-negative intervals.
All adenopathies were more common among HIVpositive intervals compared with seroconvertors, andwith the exception of neck nodes -were more common among men compared with women regardless of serostatus. Physical examination for adenopathies may be less sensitive in women due to increased amounts of adipose tissue and anatomical differences in the inguinal area.
ESR is a nonspecific and evidently early marker for inflammation, as it was elevated in seroconvertors compared with HIV-negative intervals, and only marginally higher in HIV-positive compared with seroconversion intervals. As previously reported, ESR was higher in women compared with men regardless of serostatus [4, 37, 38] .
Scoring systems combining signs, symptoms, and behaviors have been evaluated in two publications from Africa [39, 40] . In our study, a cutoff of one or more symptoms and physical examination findings had a sensitivity of 64.6% and a specificity of 59.7%, but a very low PPV. By sex, a cutoff of one or more symptoms and physical examination findings had a higher sensitivity in men vs. women (73 vs. 57.6%). Even small increases in PPV result in considerable decreases in sensitivity, leading to the accurate identification of fewer recent HIV seroconversions. Decreases in sensitivity must be weighed against increases in specificity and PPV, which confer increased cost effectiveness.
We found significantly increasing set-point viral load with increasing number of symptoms/physical examination findings. In a prospective cohort in San Francisco, increased number of symptoms associated with acute HIV infection was also associated with high initial viral load [41] . Importantly, a higher number and severity of acute symptoms have also been shown to increase disease progression and mortality [40, 42, 43] .
Our analysis was subject to several important limitations. First, we designated 3-monthly follow-up visits as seroconversion intervals or nonseroconversion intervals; transient signs may have been missed and symptoms occurring early in the 3-month period may have been subject to differential recall bias. This would artificially lower the prevalence of reported symptoms [44] . Although our intent was to blind clinicians to patient's serostatus, physical examinations conducted at a nonannual visit might have been conducted with knowledge that an HIV seroconversion was likely, leading to ascertainment bias. If such bias occurred, it would tend to over-represent the associations of physical examination findings with seroconversion. Our results are not generalizable to all persons in Zambia, or to other geographic areas.
Our study also had significant strengths. We collected data from a large, stable cohort of discordant couples, and were therefore able to consistently collect data from a large group of HIV-negative persons with high risk for HIV infection. Screening for HIV infection was performed at regular intervals, independent of clinical suspicion of HIV infection, so ascertainment of seroconversion was unbiased. Our study, thus, allowed comparison of nonspecific signs and symptoms of acute and chronic HIV to the 'background' rate found in HIV-negative intervals, and to compare men and women.
Conclusion
According to our data, collection of self-reported symptoms and physical examination data are not likely to be productive strategies for targeting HIV screening in Zambia, although acute HIV infection may be an important differential for patients presenting with malaria syndrome and bilateral adenopathy. Implementation of existing approaches, including routine HIV counseling and testing of cohabiting couples and other sexual partnerships, remains an important element of a comprehensive strategy both for identifying those living with HIV infection, and reducing the risk of HIV transmission in serodiscordant couples.
